共 40 条
Recombinant rabies virus as potential live-viral Vaccines for HIV-1
被引:98
作者:
Schnell, MJ
Foley, HD
Siler, CA
McGettigan, JP
Dietzschold, B
Pomerantz, RJ
机构:
[1] Thomas Jefferson Univ, Jefferson Med Coll, Ctr Human Virol, Dorrance H Hamilton Labs, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Jefferson Med Coll, Dept Mol Pharmacol & Biochem, Dorrance H Hamilton Labs, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Jefferson Med Coll, Dept Microbiol & Immunol, Dorrance H Hamilton Labs, Philadelphia, PA 19107 USA
[4] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Dorrance H Hamilton Labs, Philadelphia, PA 19107 USA
来源:
关键词:
rhabdoviruses;
RNA;
envelope;
gp160;
D O I:
10.1073/pnas.050589197
中图分类号:
O [数理科学和化学];
P [天文学、地球科学];
Q [生物科学];
N [自然科学总论];
学科分类号:
07 ;
0710 ;
09 ;
摘要:
Recombinant, replication-competent rabies virus (RV) vaccine strain-based vectors were developed expressing HIV type I (HIV-1) envelope glycoprotein (gp160) from both a laboratory-adapted (CXCR4-tropic) and a primary (dual-tropic) HIV-1 isolate. An additional transcription stop/start unit within the RV genome was used to express HIV-1 gp160 in addition to the other RV proteins, The HIV-1 gp160 protein was stably and functionally expressed, as indicated by fusion of human T cell lines after infection with the recombinant RVs, Inoculation of mice with the recombinant RVs expressing HIV-1 gp160 induced a strong humoral response directed against the HIV-1 envelope protein after a single boost with recombinant HIV-1 gp120 protein. Moreover, high neutralization titers up to 1:800 against HIV-1 could be detected in the mouse sera. These data indicate that a live recombinant RV, a rhabdovirus, expressing HIV-1 gp160 may serve as an effective vector for an HIV-1 vaccine.
引用
收藏
页码:3544 / 3549
页数:6
相关论文